What does it take to turn in silico innovation into real impact for patients?
At AAD 2026, the ISA Working Group session brings together key voices from across the ecosystem to tackle exactly that question.
The In Silico Application (ISA) WG highlights the “village” needed to make in silicotechnologies truly work in practice — from standards to regulation to engineering.
The session will open with speeches by Matthieu CHAREYRE, Erica Beaucage-Gauvreau, and Karl Bass, setting the stage for a dynamic exchange.This will be followed by a roundtable discussion moderated by Dr. René Bombien, featuring Charlott Danielson, Brent Craven, Julien Clin, Vijay Govindarajan, and Dr. Richard Assaker, exploring how U.S. and EU standard development, regulatory science, and conformity assessment are converging in the field of computational modelling and simulation.
By aligning technical rigor with real-world implementation, this session will show why collaboration isn’t optional — it’s essential.
Because in the end, all roads in in silico innovation should lead to one place: meaningful patient impact.
